| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 8 Sep 2025 Issue date: 11 May 2021 | 30 Jun 2020 | 11 May 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 11 May 2021 | 26 Jun 2020 | 11 May 2021 |
| Utility: A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 6 May 2021 | 14 Jan 2021 | 6 May 2021 |
| Utility: A*03 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 6 May 2021 | 14 Jan 2021 | 6 May 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 4 May 2021 | 4 Nov 2020 | 4 May 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers Filling date: 8 Sep 2025 Issue date: 4 May 2021 | 18 Feb 2020 | 4 May 2021 |
| Utility: Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Filling date: 8 Sep 2025 Issue date: 4 May 2021 | 13 Feb 2019 | 4 May 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 22 Apr 2021 | 10 Dec 2020 | 22 Apr 2021 |
| Utility: NOVEL CELL EPITOPES AND COMBINATION OF CELL EPITOPES FOR USE IN THE IMMUNOTHERAPY OF MYELOMA AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 15 Apr 2021 | 16 Dec 2020 | 15 Apr 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 15 Apr 2021 | 16 Dec 2020 | 15 Apr 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST EPITHELIAL OVARIAN CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 15 Apr 2021 | 9 Dec 2020 | 15 Apr 2021 |
| Utility: NOVEL ENGINEERED T CELL RECEPTORS AND IMMUNE THERAPY USING THE SAME Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 | 17 Dec 2020 | 8 Apr 2021 |
| Utility: TRANSFECTED T-CELLS AND T-CELL RECEPTORS FOR USE IN IMMUNOTHERAPY AGAINST CANCERS Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 | 17 Dec 2020 | 8 Apr 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 | 16 Dec 2020 | 8 Apr 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 | 10 Dec 2020 | 8 Apr 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST OVARIAN CANCER AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 8 Apr 2021 | 10 Dec 2020 | 8 Apr 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various cancers Filling date: 8 Sep 2025 Issue date: 6 Apr 2021 | 9 Dec 2016 | 6 Apr 2021 |
| Utility: B*44 RESTRICTED PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CANCERS AND RELATED METHODS Filling date: 8 Sep 2025 Issue date: 1 Apr 2021 | 10 Dec 2020 | 1 Apr 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST LUNG CANCER, INCLUDING NSCLC AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 1 Apr 2021 | 9 Dec 2020 | 1 Apr 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 25 Mar 2021 | 21 Oct 2020 | 25 Mar 2021 |
| Utility: Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Filling date: 8 Sep 2025 Issue date: 23 Mar 2021 | 18 Sep 2019 | 23 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 8 Sep 2025 Issue date: 16 Mar 2021 | 26 Jun 2020 | 16 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 16 Mar 2021 | 24 Jun 2020 | 16 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 16 Mar 2021 | 12 Jun 2020 | 16 Mar 2021 |
| Utility: *03 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 8 Sep 2025 Issue date: 16 Mar 2021 | 19 Jun 2019 | 16 Mar 2021 |
| Utility: Personalized immunotherapy against several neuronal and brain tumors Filling date: 8 Sep 2025 Issue date: 16 Mar 2021 | 3 Nov 2014 | 16 Mar 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 11 Mar 2021 | 4 Nov 2020 | 11 Mar 2021 |
| Utility: NOVEL PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST HEAD AND NECK SQUAMOUS CELL CARCINOMA AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 11 Mar 2021 | 21 Oct 2020 | 11 Mar 2021 |
| Utility: Immunotherapy against several tumors including neuronal and brain tumors Filling date: 8 Sep 2025 Issue date: 9 Mar 2021 | 2 Aug 2016 | 9 Mar 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 4 Mar 2021 | 13 Nov 2020 | 4 Mar 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 4 Mar 2021 | 13 Nov 2020 | 4 Mar 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 4 Mar 2021 | 4 Nov 2020 | 4 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against NHL and other cancers Filling date: 8 Sep 2025 Issue date: 2 Mar 2021 | 30 Sep 2020 | 2 Mar 2021 |
| Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers Filling date: 8 Sep 2025 Issue date: 2 Mar 2021 | 29 Jun 2020 | 2 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 8 Sep 2025 Issue date: 2 Mar 2021 | 29 Jun 2020 | 2 Mar 2021 |
| Utility: Immunotherapy against several tumors including gastrointestinal and gastric cancer Filling date: 8 Sep 2025 Issue date: 2 Mar 2021 | 5 Jun 2020 | 2 Mar 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various tumors Filling date: 8 Sep 2025 Issue date: 2 Mar 2021 | 6 Aug 2018 | 2 Mar 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 | 4 Nov 2020 | 25 Feb 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 | 4 Nov 2020 | 25 Feb 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 | 4 Nov 2020 | 25 Feb 2021 |
| Utility: PEPTIDES AND COMBINATION OF PEPTIDES OF NON-CANONICAL ORIGIN FOR USE IN IMMUNOTHERAPY AGAINST DIFFERENT TYPES OF CANCERS Filling date: 8 Sep 2025 Issue date: 25 Feb 2021 | 4 Nov 2020 | 25 Feb 2021 |
| Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Filling date: 8 Sep 2025 Issue date: 23 Feb 2021 | 30 Sep 2020 | 23 Feb 2021 |
| Utility: A*03 restricted peptides for use in immunotherapy against cancers and related methods Filling date: 8 Sep 2025 Issue date: 23 Feb 2021 | 9 Jul 2018 | 23 Feb 2021 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 8 Sep 2025 Issue date: 23 Feb 2021 | 22 Apr 2016 | 23 Feb 2021 |
| Utility: METHOD FOR THE CHARACTERIZATION OF PEPTIDE:MHC BINDING POLYPEPTIDES Filling date: 8 Sep 2025 Issue date: 18 Feb 2021 | 11 Aug 2020 | 18 Feb 2021 |
| Utility: Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Filling date: 8 Sep 2025 Issue date: 16 Feb 2021 | 16 Jun 2020 | 16 Feb 2021 |
| Utility: Immunotherapy against several tumors including neuronal and brain tumors Filling date: 8 Sep 2025 Issue date: 16 Feb 2021 | 2 Aug 2016 | 16 Feb 2021 |
| Utility: METHODS FOR PEPTIDE MASS SPECTROMETRY FRAGMENTATION PREDICTION Filling date: 8 Sep 2025 Issue date: 11 Feb 2021 | 7 Aug 2020 | 11 Feb 2021 |
| Utility: NOVEL PEPTIDES AND COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPY AGAINST RENAL CELL CARCINOMA (RCC) AND OTHER CANCERS Filling date: 8 Sep 2025 Issue date: 4 Feb 2021 | 16 Oct 2020 | 4 Feb 2021 |
| Utility: RECRUITING AGENT FURTHER BINDING AN MHC MOLECULE Filling date: 8 Sep 2025 Issue date: 4 Feb 2021 | 30 Jul 2020 | 4 Feb 2021 |
